Create one master record for the packaging project
A designer should receive controlled product information rather than assemble a label from a catalogue screenshot, a sales email and a previous customer’s carton. Build a master record containing the approved product identifier, supplied form, quantity statement, pack count, intended-use wording and storage statement. Assign an owner to each field so commercial edits cannot silently change technical meaning.
Use the same record for the OEM project specification and artwork brief. Separate the brand’s display name from the identifier used by the manufacturer or testing laboratory. If the display name differs, document the mapping. The supplier evidence file described in our qualification checklist should preserve that connection after the labels have been applied.
For an initial proof, use clearly marked placeholders for variable lot and date fields. The approval file should say which values are placeholders and where production values will come from. This prevents a convincing demonstration label from being mistaken for released production artwork.
Proofread quantity statements as technical data
A label saying “10 mg” needs an agreed meaning. It may refer to a specified nominal fill quantity, supplied powder mass or another declared basis; the artwork should follow the signed specification. Do not change mg to mL, omit a concentration denominator or copy a strength from a different vial size. A matching label photograph is not an analytical measurement of fill quantity.
Include the carton statement in the same review. “10 vials” describes a pack count, while a mass per vial describes a different attribute. Reviewers should check both, alongside the product name and units on the quotation and packing list. If a purchasing decision depends on net peptide content, resolve that basis before printing. See the COA quantity example for the distinction.
A useful proof record places the vial statement and carton statement side by side. Record any approved rounding convention in the technical specification before the designer applies it. The proof should not introduce a new interpretation of quantity simply to make a line fit.
| Proof field | Match against | Common discrepancy to prevent |
|---|---|---|
| Product name/form | Approved specification | Obsolete salt or product variant |
| Quantity/unit | Order and agreed quantity basis | mg copied as mL |
| Pack count | Carton configuration | Vial count copied from another project |
| Lot code | Batch-mapping record | Brand code with no manufacturer link |
| Storage/date fields | Approved technical statements | Unsupported shelf-life or temperature claim |
Keep human-readable text and encoded data consistent
If the project uses GS1 identifiers, use the appropriate GS1 data definitions rather than designing a lookalike barcode. The GS1 Application Identifier reference distinguishes 01 for GTIN, 10 for batch/lot and 17 for expiration date in YYMMDD format. These identifiers describe data fields; they do not certify the material or grant a regulatory status.
A QR code containing an ordinary web address is a different arrangement. State what the symbol should resolve to and what information it is intended to carry. Test the final printed proof with the intended scanning system and compare the decoded data with the visible label. Do not publish a readable demonstration code as if it were an assigned production identifier. Applicable coding requirements depend on the project and market.
Keep the scan result with the proof revision that was tested. If the artwork is resized or the printing process changes, ask the packaging team whether another verification is needed. This is a proposed project control, not a claim that a particular barcode has been validated.
Approve the file and the variable-data rules
Record the artwork filename, revision, approval date and approving roles. Keep a reference proof showing the complete vial and carton surfaces, not only the attractive front panel. Mark variable fields separately from fixed artwork, with a rule for their source. The team applying a lot code needs to know which approved batch record supplies it and who checks the printed output.
ICH Q7 discusses packaging/label controls and batch traceability in pharmaceutical API manufacture. It is a quality-system reference here, not a claim that a private-label research project is a GMP-certified drug operation. For this proposed workflow, retain approval evidence and require a fresh review when a technical field changes, even when the visual design remains the same.
Include the back panel and any removable label in the approval packet. A short brand name on the front does not remove the need to check technical fields elsewhere. Give the production team one clearly identified approved version rather than several similarly named final files.
Keep a short release packet
- Approved material specification and order.
- Vial and carton artwork revisions.
- Variable-data source and lot-code mapping.
- Physical or printed proof acceptance record.
- Documented disposition of any discrepancy.
Reject unsupported claims before the print run
Remove efficacy claims, approval logos or certificate statements that the project cannot substantiate. A research-use statement does not turn an otherwise noncompliant product presentation into a compliant one. Intended use, customer communications and destination rules require their own review. Keep the artwork approval within its actual scope: it confirms the agreed packaging information, not clinical safety or market authorisation.
Bring the final checklist to a packaging enquiry with the proposed vial format and destination. MOQ, lead time and technical documentation depend on the confirmed project; this article supplies no universal manufacturing minimum or delivery promise. Original records and current approved artwork should remain available to the receiving team after shipment.
When an unsupported statement is removed, check the linked product page and sales attachment as well. Keep the approved communication set with the artwork revision. Packaging, online descriptions and quotations should describe the same intended scope rather than giving buyers conflicting impressions.
Frequently asked questions
Should the vial’s mg value match the product page automatically?
It should match the signed order and material specification. A catalogue page is an enquiry reference; verify the exact variant, unit and quantity basis before approving artwork.
Is a QR code the same as a GS1 identifier?
No. A QR symbol may encode an ordinary URL or other data. A GS1 implementation has defined identification and data rules that must be applied correctly when used.
Can changing only the displayed product name require new approval?
Yes. A display-name change can break the connection to specifications, laboratory reports or batch records. Review the mapping and affected files before printing.
Does approved artwork confirm a peptide’s analytical quality?
No. Artwork approval checks packaging information and its agreed sources. Analytical quality requires the separate specification and lot-specific evidence.
Sources and editorial basis
References checked on 31 October 2026. The checklists and examples are editorial procurement guidance. Pharmaceutical standards are cited for their stated scope; they do not certify this supplier, a research material or a shipment.
Scope: B2B research-material procurement. This article provides no dosing, treatment or human-use instructions. Product-specific acceptance requires the signed specification and actual lot records.
Request a specification and document review with the material identifier, supplied form, quantity basis and destination. Availability and test scope require project confirmation.